Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2002 Jul;87(1):6–9. doi: 10.1136/adc.87.1.6

Newborn and childhood screening programmes: criteria, evidence, and current policy

D Elliman 1, C Dezateux 1, H Bedford 1
PMCID: PMC1751146  PMID: 12089109

Full Text

The Full Text of this article is available as a PDF (88.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E. Evaluating screening tests and screening programmes. Arch Dis Child. 1990 Jul;65(7):792–795. doi: 10.1136/adc.65.7.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andresen B. S., Dobrowolski S. F., O'Reilly L., Muenzer J., McCandless S. E., Frazier D. M., Udvari S., Bross P., Knudsen I., Banas R. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet. 2001 May 8;68(6):1408–1418. doi: 10.1086/320602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baron-Cohen S., Wheelwright S., Cox A., Baird G., Charman T., Swettenham J., Drew A., Doehring P. Early identification of autism by the CHecklist for Autism in Toddlers (CHAT). J R Soc Med. 2000 Oct;93(10):521–525. doi: 10.1177/014107680009301007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beasley M. G., Costello P. M., Smith I. Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971. Q J Med. 1994 Mar;87(3):155–160. [PubMed] [Google Scholar]
  5. Carpenter K., Wiley V., Sim K. G., Heath D., Wilcken B. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch Dis Child Fetal Neonatal Ed. 2001 Sep;85(2):F105–F109. doi: 10.1136/fn.85.2.F105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davies S. C., Cronin E., Gill M., Greengross P., Hickman M., Normand C. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assess. 2000;4(3):i-v, 1-99. [PubMed] [Google Scholar]
  7. Davis A., Bamford J., Wilson I., Ramkalawan T., Forshaw M., Wright S. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. Health Technol Assess. 1997;1(10):i-iv, 1-176. [PubMed] [Google Scholar]
  8. Godward S., Dezateux C. Surgery for congenital dislocation of the hip in the UK as a measure of outcome of screening. MRC Working Party on Congenital Dislocation of the Hip. Medical Research Council. Lancet. 1998 Apr 18;351(9110):1149–1152. doi: 10.1016/s0140-6736(97)10466-4. [DOI] [PubMed] [Google Scholar]
  9. Hall D. M. Growth monitoring. Arch Dis Child. 2000 Jan;82(1):10–15. doi: 10.1136/adc.82.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Järvinen O., Lehesjoki A. E., Lindlöf M., Uutela A., Käriäinen H. Carrier testing of children for two X-linked diseases: A retrospective study of comprehension of the test results and social and psychological significance of the testing. Pediatrics. 2000 Dec;106(6):1460–1465. doi: 10.1542/peds.106.6.1460. [DOI] [PubMed] [Google Scholar]
  11. Law J., Boyle J., Harris F., Harkness A., Nye C. Screening for speech and language delay: a systematic review of the literature. Health Technol Assess. 1998;2(9):1–184. [PubMed] [Google Scholar]
  12. Lehmann H. P., Hinton R., Morello P., Santoli J. Developmental dysplasia of the hip practice guideline: technical report. Committee on Quality Improvement, and Subcommittee on Developmental Dysplasia of the Hip. Pediatrics. 2000 Apr;105(4):E57–E57. doi: 10.1542/peds.105.4.e57. [DOI] [PubMed] [Google Scholar]
  13. Liebl B., Fingerhut R., Röschinger W., Muntau A., Knerr I., Olgemöller B., Zapf A., Roscher A. A. Modellprojekt zur Neuordnung des Neugeborenen-Screenings in Bayern: Konzeption und erste Ergebnisse. Gesundheitswesen. 2000 Apr;62(4):189–195. doi: 10.1055/s-2000-10856. [DOI] [PubMed] [Google Scholar]
  14. Murray J., Cuckle H., Taylor G., Littlewood J., Hewison J. Screening for cystic fibrosis. Health Technol Assess. 1999;3(8):i-iv, 1-104. doi: 10.2165/00115677-199803040-00001. [DOI] [PubMed] [Google Scholar]
  15. Patel H., Canadian Task Force on Preventive Health Care Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns. CMAJ. 2001 Jun 12;164(12):1669–1677. [PMC free article] [PubMed] [Google Scholar]
  16. Pollitt R. J., Leonard J. V. Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child. 1998 Aug;79(2):116–119. doi: 10.1136/adc.79.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pourfarzam M., Morris A., Appleton M., Craft A., Bartlett K. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet. 2001 Sep 29;358(9287):1063–1064. doi: 10.1016/S0140-6736(01)06199-2. [DOI] [PubMed] [Google Scholar]
  18. Rahi J. S., Dezateux C. National cross sectional study of detection of congenital and infantile cataract in the United Kingdom: role of childhood screening and surveillance. The British Congenital Cataract Interest Group. BMJ. 1999 Feb 6;318(7180):362–365. doi: 10.1136/bmj.318.7180.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Simons W. F., Fuggle P. W., Grant D. B., Smith I. Educational progress, behaviour, and motor skills at 10 years in early treated congenital hypothyroidism. Arch Dis Child. 1997 Sep;77(3):219–222. doi: 10.1136/adc.77.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Smith L. K., Thompson J. R., Woodruff G. Children's vision screening: impact on inequalities in central England. J Epidemiol Community Health. 1995 Dec;49(6):606–609. doi: 10.1136/jech.49.6.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Snowdon S. K., Stewart-Brown S. L. Preschool vision screening. Health Technol Assess. 1997;1(8):i-iv, 1-83. [PubMed] [Google Scholar]
  22. Wilson C. J., Champion M. P., Collins J. E., Clayton P. T., Leonard J. V. Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis. Arch Dis Child. 1999 May;80(5):459–462. doi: 10.1136/adc.80.5.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zeuner D., Ades A. E., Karnon J., Brown J., Dezateux C., Anionwu E. N. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technol Assess. 1999;3(11):i-v, 1-186. [PubMed] [Google Scholar]
  24. Zytkovicz T. H., Fitzgerald E. F., Marsden D., Larson C. A., Shih V. E., Johnson D. M., Strauss A. W., Comeau A. M., Eaton R. B., Grady G. F. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem. 2001 Nov;47(11):1945–1955. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES